The synthesis and the physico-chemical characterisation of a novel solid phase, designed for iron(III) sorption, are presented. The solid (indicated in the following as DFO-SAMMS) is made with a hydroxamate siderophore, the deferoxamine (DFO), covalently bound on a self-assembled monolayer on mesoporous silica (SAMMS). The data demonstrate that the DFO molecules are bound to the solid material, grafted on the surface and do not enter the silica pores. A new one-pot synthesis is presented in which DFO is dissolved in DMSO, and left to react with GPTMS with stirring overnight. In the same mixture, SAMMS is added to get the final product. The optimisation of experimental conditions of this novel one-pot synthesis is presented, with results ind...
Siderophores wich are naturally complexin iron ( III ) are synthesized and secreted by microorganism...
Siderophores are produced by a number of microbes to capture iron with outstandingly high affinity, ...
A simple, small size, and low cost sensor based on a Deferoxamine Self Assembled Monolayer (DFO-SAM)...
The synthesis and the physico-chemical characterisation of a novel solid phase, designed for iron(ii...
A simple and rapid solid-phase spectrophotometric procedure to determine free Fe(III) in environment...
Successful in vivo chelation treatment of iron(III) overload pathologies requires that a significant...
Successful in vivo chelation treatment of iron(III) overload pathologies requires that a significant...
The paper presents the synthesis and preliminary characterization of two novel solid-phase sorbents ...
AbstractA simple and rapid solid-phase spectrophotometric procedure to determine free Fe(III) in env...
Since the emergence of deferiprone as an iron(iii) chelating drug, hydroxypyridinones have been inte...
Deferoxamine (DFO) is a siderophore widely studied for its ability to bind iron(III) strongly. Thank...
The aim of this work was the synthesis of hybrid materials of iron (II)-based therapeutic systems vi...
The use of oral iron integration is commonly recommended for the treatment of iron deficiency, never...
Siderophores wich are naturally complexin iron ( III ) are synthesized and secreted by microorganism...
Siderophores are produced by a number of microbes to capture iron with outstandingly high affinity, ...
A simple, small size, and low cost sensor based on a Deferoxamine Self Assembled Monolayer (DFO-SAM)...
The synthesis and the physico-chemical characterisation of a novel solid phase, designed for iron(ii...
A simple and rapid solid-phase spectrophotometric procedure to determine free Fe(III) in environment...
Successful in vivo chelation treatment of iron(III) overload pathologies requires that a significant...
Successful in vivo chelation treatment of iron(III) overload pathologies requires that a significant...
The paper presents the synthesis and preliminary characterization of two novel solid-phase sorbents ...
AbstractA simple and rapid solid-phase spectrophotometric procedure to determine free Fe(III) in env...
Since the emergence of deferiprone as an iron(iii) chelating drug, hydroxypyridinones have been inte...
Deferoxamine (DFO) is a siderophore widely studied for its ability to bind iron(III) strongly. Thank...
The aim of this work was the synthesis of hybrid materials of iron (II)-based therapeutic systems vi...
The use of oral iron integration is commonly recommended for the treatment of iron deficiency, never...
Siderophores wich are naturally complexin iron ( III ) are synthesized and secreted by microorganism...
Siderophores are produced by a number of microbes to capture iron with outstandingly high affinity, ...
A simple, small size, and low cost sensor based on a Deferoxamine Self Assembled Monolayer (DFO-SAM)...